The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.60
Bid: 27.60
Ask: 27.90
Change: 0.00 (0.00%)
Spread: 0.30 (1.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 27.60
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-End Trading Update

12 Oct 2016 07:00

RNS Number : 2755M
Marston's PLC
12 October 2016
 

 

MARSTON'S PLC 12 October 2016

YEAR-END TRADING UPDATE

 

Marston's PLC ("the Group") issues the following update on trading for the year ended 1 October 2016. The preliminary results will be announced on 24 November 2016.

 

Trading

We have made good progress this year with underlying profit before tax in line with management expectations.

 

In Destination and Premium, like-for-like sales were 2.3% ahead of last year including food like-for-like sales growth of 1.7% and wet like-for-like sales growth of 2.3%, underpinned by strong growth in room income. In the last 10 weeks of the period like-for-like sales have grown 1.8%. Operating margin is in line with last year and we completed 22 new pubs and bars and six lodges in the financial year just ended. In the 2017 Financial Year we plan to open at least 22 pubs and bars and at least five lodges with the openings programme weighted towards the second half year. We continue to have a good pipeline of sites to maintain similar levels of expansion for the foreseeable future.

 

In Taverns, like-for-like sales were 2.7% ahead of last year, with growth of 2.0% in the last 10 weeks including a strong performance in our franchise estate.

 

In Leased, like-for-like profits are estimated to be up 2% compared to last year.

 

In Brewing, our beer brands have performed very strongly, with own-brand volumes up 13% for the financial year and profits in line with management expectations.

 

Ralph Findlay, Chief Executive Officer, commented:

"Marston's has delivered another year of solid progress with underlying growth across all of our pub divisions and continued outstanding performance from our market-leading beer business. Trading has continued at similar levels since the year end which is encouraging. In addition, our new pub-restaurants, lodges and Revere premium pubs all continue to perform well.

Looking forward, our estate is well balanced and we have a well-developed, strong pipeline of sites to continue our current level of expansion."

 

 

ENQUIRIES:

 

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2020

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood

 

NOTES TO EDITORS

· Marston's is a leading pub operator and independent brewer.

· It has an estate of around 1,560 pubs situated nationally, comprising managed, franchised and leased pubs.

· It is the UK's leading brewer of premium cask and bottled ales, including Marston's Pedigree, Thwaites Wainwright, Lancaster Bomber and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers.

· Marston's employs around 13,500 people.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLBDGCBBBGLB
Date   Source Headline
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company
18th Feb 20221:09 pmRNSHolding(s) in Company
25th Jan 20222:35 pmRNSTrading for the period to 22 Jan 2022 - Correction
25th Jan 20222:20 pmRNSResult of AGM
25th Jan 20227:00 amRNSTrading for the 16-week period to 22 January 2022
10th Jan 20223:55 pmRNSBlock listing Interim Review
20th Dec 20214:15 pmRNSAnnual Financial Report
7th Dec 202111:11 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSRESULTS FOR THE 52 WEEKS ENDED 2 OCTOBER 2021
19th Oct 20219:05 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSYear end trading update
30th Sep 202110:43 amRNSDisclosure of 2020/21 LTIP performance targets
16th Sep 20213:00 pmRNSDirector Declaration re: New Directorship
9th Sep 20212:30 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSTrading Update
20th Jul 20217:08 amRNSDirectorate Change
13th Jul 20218:36 amRNSBlock listing Interim Review
6th Jul 20217:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.